Same bull, slightly smaller megaphone
RBC Capital took a tiny haircut to its IBM price target, cutting it from $361 to $330. But before you start reaching for the tissue box, the firm kept its Outperform rating, which is the investing equivalent of saying, “We still like the movie, we just think the sequel might not be quite as explosive.”
Why this matters
IBM’s been trading around $251, and that’s still roughly 23% below its 52-week high of $324.90. So even after the target trim, the stock still has room to run in RBC’s eyes — just not quite as much as before. That’s important for a name like IBM, where sentiment can hinge on whether the market believes the company’s AI-and-software glow-up has more gas left in the tank.
The valuation vibe shift
The real story here isn’t panic, it’s math. RBC appears to be dialing back expectations because IBM’s valuation is getting less bargain-bin and more “premium section.” InvestingPro’s own read says the stock still looks undervalued versus fair value, which leaves you with that classic Wall Street tug-of-war: the stock isn’t cheap-cheap anymore, but bulls still think the long game works.
Big picture
For investors, this is less a warning flare and more a subtle temperature check. IBM still has analyst support, but the easy upside story is getting a little more crowded. Big picture: when the valuation debate starts getting louder, the next catalyst has to do more of the heavy lifting.